Monument Capital Management Purchases 122 Shares of Elevance Health, Inc. (NYSE:ELV)

Monument Capital Management boosted its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 23.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 642 shares of the company’s stock after acquiring an additional 122 shares during the period. Monument Capital Management’s holdings in Elevance Health were worth $303,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in the business. Lawson Kroeker Investment Management Inc. NE increased its holdings in shares of Elevance Health by 0.3% in the 3rd quarter. Lawson Kroeker Investment Management Inc. NE now owns 27,465 shares of the company’s stock valued at $11,959,000 after acquiring an additional 69 shares during the period. Avior Wealth Management LLC lifted its position in shares of Elevance Health by 12.4% during the third quarter. Avior Wealth Management LLC now owns 607 shares of the company’s stock valued at $264,000 after buying an additional 67 shares during the last quarter. Leonard Rickey Investment Advisors P.L.L.C. purchased a new position in shares of Elevance Health in the 3rd quarter worth approximately $333,000. GHP Investment Advisors Inc. raised its stake in shares of Elevance Health by 2.9% during the 3rd quarter. GHP Investment Advisors Inc. now owns 13,744 shares of the company’s stock worth $6,241,000 after acquiring an additional 392 shares in the last quarter. Finally, Farmers & Merchants Trust Co of Chambersburg PA lifted its position in Elevance Health by 1.8% during the third quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 3,949 shares of the company’s stock valued at $1,719,000 after acquiring an additional 69 shares during the last quarter. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Elevance Health Trading Up 0.1 %

Shares of NYSE:ELV opened at $532.17 on Tuesday. The company has a market capitalization of $123.69 billion, a PE ratio of 20.11, a PEG ratio of 1.16 and a beta of 0.78. The business has a 50 day moving average of $509.68 and a two-hundred day moving average of $484.51. Elevance Health, Inc. has a 12-month low of $412.00 and a 12-month high of $539.11. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 0.54.

Elevance Health (NYSE:ELV) last released its quarterly earnings data on Thursday, April 18th. The company reported $10.64 EPS for the quarter, beating analysts’ consensus estimates of $10.54 by $0.10. The firm had revenue of $42.27 billion for the quarter, compared to analysts’ expectations of $42.49 billion. Elevance Health had a return on equity of 20.62% and a net margin of 3.64%. The firm’s quarterly revenue was up .9% on a year-over-year basis. During the same period in the prior year, the firm posted $9.46 earnings per share. As a group, analysts forecast that Elevance Health, Inc. will post 37.24 EPS for the current year.

Elevance Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 10th will be issued a $1.63 dividend. The ex-dividend date is Monday, June 10th. This represents a $6.52 annualized dividend and a yield of 1.23%. Elevance Health’s dividend payout ratio (DPR) is currently 24.64%.

Insider Buying and Selling at Elevance Health

In other Elevance Health news, Director Ramiro G. Peru sold 753 shares of Elevance Health stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $500.00, for a total transaction of $376,500.00. Following the completion of the sale, the director now directly owns 9,109 shares in the company, valued at $4,554,500. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.29% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on ELV shares. Wells Fargo & Company increased their price objective on Elevance Health from $557.00 to $600.00 and gave the company an “overweight” rating in a report on Friday. Barclays increased their price objective on shares of Elevance Health from $584.00 to $621.00 and gave the company an “overweight” rating in a research report on Friday. UBS Group boosted their target price on shares of Elevance Health from $585.00 to $605.00 and gave the stock a “buy” rating in a research report on Friday. Truist Financial reissued a “buy” rating and set a $600.00 price objective (up from $580.00) on shares of Elevance Health in a report on Friday. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $580.00 price target on shares of Elevance Health in a research report on Wednesday, April 10th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $587.64.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.